Alison Bays, MD

Alison Bays, MD

Biologics, Module 6

B-cell death row

Alison Bays, MD's avatar
Alison Bays, MD
Jul 06, 2026
∙ Paid

Well, this doesn’t fit the memory palace, but here we go anyway!

B-cell death row, five ways to go. These drugs target B cells through depletion or starvation — each a different way to eliminate rogue B cells driving autoimmunity.

“B-cell death row, five ways to go:
RITUXIMAB — CD20’s last RITE.
OBI — the OBITUARY, same target, deadlier bite.
INE-B — INEVITA…

User's avatar

Continue reading this post for free, courtesy of Alison Bays, MD.

Or purchase a paid subscription.
© 2026 Alison Bays · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture